Pure Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.5%.

Top 14 shareholders own 36.21% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.75%	Filip Jelen	257,817	zł2.0m	33.2%	no data
7.51%	Powszechna Kasa Oszczednosci Bank Polski Spólka Akcyjna	250,065	zł2.0m	0%	no data
5.7%	Tadeusz Wesolowski	189,720	zł1.5m	0%	no data
4.6%	Forum Towarzystwo Funduszy Inwestycyjnych S.A.	153,220	zł1.2m	15.2%	0.15%
3.62%	Allianz Asset Management GmbH	120,630	zł946.9k	-46.4%	no data
2.43%	Andrzej Trznadel	81,000	zł635.8k	0%	no data
1.84%	Norges Bank Investment Management	61,080	zł479.5k	12.8%	no data
0.79%	Andrzej Kierzkowski	26,221	zł205.8k	0%	no data
0.59%	Maciej Mazurek	19,761	zł155.1k	0%	no data
0.58%	Superfund Towarzystwo Funduszy Inwestycyjnych S.a.	19,295	zł151.5k	0%	0.26%
0.34%	Piotr Jakimowicz	11,194	zł87.9k	0%	no data
0.32%	BNPP Asset Management Holding	10,770	zł84.5k	0%	no data
0.096%	Romuald Harwas	3,205	zł25.2k	0%	no data
0.03%	Pieter Spee	1,000	zł7.9k	0%	no data